Entries by Ayal Ronen

Presentation in association with Holland BIO: NIH/DOD Non-dilutive Funding Opportunities; Non-US Applicants are Welcome! Leiden Science Park – May 12th, 2014 – Leiden

!NIH/DOD Non-dilutive Funding Opportunities; Non-US Applicants are Welcome Presenter:  Ayal Ronen, Vice President, FreeMind Group Agenda: 9:00-09:30 Registration and networking breakfast 09:30-10:30 Presentation 10:30-10:45 Q&A 11:00-12:00 Meet the expert – 1X1 meetings with the FreeMind team REGISTRATION Presentation Outline Currently, the National Institutes of Health (NIH) are actively funding 1,124 projects amounting to $1.3B, taking […]

/0 Comments/by

University-Industry Partnerships; NIH/DOD Funded Industry – Academic Collaborations

The FreeMind Group and the 9th Annual Non-Dilutive Funding Summit is proud to host Dr. Anthony Boccanfuso, Executive Director, The National Academies’ University-Industry Demonstration Partnership (UIDP) who will discuss in his presentation industry-academic collaborations and how the life science industry can leverage such ties to secure non-diltuive capital to fund their R&D activities. Following the […]

/0 Comments/by

Presentation: 2014 Non-dilutive Funding Forecast

The 9th Annual Non-dilutive Funding Summit is proud to host Ram May-Ron, Managing Partner,  FreeMind Group who will give a presentation on a “2014 Non-Dilutive Funding Forecast”. In his presentation Mr May-Ron will share his insight into Life Science funding trends and specifically non-dilutive funding as the driving force in this sector.

/0 Comments/by

Direct Phase II SBIR Grants to Support Biomedical Technology Development

The purpose of this funding opportunity announcement (FOA) is to encourage applications to the newly authorized Direct-to-Phase II SBIR grant mechanism.  Applications are invited from eligible United States small business concerns (SBCs) that have demonstrated the scientific and technical merit and feasibility of the prototype stage of developing a biomedical technology that has commercial potential, […]

/0 Comments/by

Partnerships in Clinical Trials

Meet FreeMind at the Partnership in Clinical trials event in Las Vegas on March 30th to discuss sources of funding able to fund your clinical trial! For more than 22 years, Partnerships has been a cornerstone for thousands of clinical executives to partner, learn, and innovate. This coming year, we’re taking PCT to a whole […]

/0 Comments/by

$580,000,000 CDMRP Awards Appropriated for 2014!

The Fiscal Year 2014 Department of Defense Appropriations Act will fund some$580,000,000 through the Congressionally Directed Medical Research Programs (CDMRP). Programs range from Oncology, ALS, Autism, through MS, Orthopedic research and more. Program Announcements will be issued during 2014, Stay Tuned!  The FreeMind Group has extensive experience in assisting clients in completing and winning such complex […]

/0 Comments/by

9th Annual Non-dilutive Funding Summit

[vc_row][vc_column width=”1/1″][pt_heading h=”h3″ heading=” Join over 250 life science industry leaders in a full day of non-dilutive funding activities at the 9th Annual Non-dilutive Funding Summit, taking place on Wednesday January 15th, 2014 at the Nikko Hotel San Francisco. ” text_align=”align-left”][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][vc_separator][/vc_column][/vc_row][vc_row][vc_column width=”1/1″][pt_text text_align=”align-left”] The summit is proud to host Dr Jodi Black of the […]

/0 Comments/by

CEOCFO Magazine Interviews Ram May-Ron, FreeMind’s Managing Partner – Securing Non-Dilutive Source Funding for Life Science Industry Companies

Interview conducted by: Lynn Fosse, Senior Editor, CEOCFO Magazine, Published – October 14, 2013 [PDF Article] CEOCFO: Mr. May-Ron, what is the vision and concept at FreeMind Group? Mr. May-Ron: What we are trying to do is just one thing. Within the life science industry there are three main sources of funding globally as well as the […]

/0 Comments/by

Harvard i-lab | Presentation by Ram May-Ron, Managing Partner FreeMind; Non-Dilutive Funding for Early-Stage Life Sciences Companies and Beyond

Presentation at the Harvard Innovation Lab by Ram May-Ron, Managing Partner FreeMind. Synopsis: Explore ways to maximize funding for science companies from non-dilutive funding sources such as NIH, DOD SBIRs (Small Business Innovation Research) and other federal and private sources. Learn about successful strategies for building a multi-submission strategy and academia-industry collaborations in the pursuit of […]

/0 Comments/by